News
Eli Lilly, makers of weight loss injection Zepbound, could soon be making its GLP-1 drug in pill form.
NPR's Scott Simon speaks to Dave Jorgenson, the creator of the Washington Post's TikTok channel, about his new media organization and the future of short-form content in newsrooms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback